94 related articles for article (PubMed ID: 2477545)
1. Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.
Edvinsson L; Ekman R; Thulin T
J Hum Hypertens; 1989 Aug; 3(4):267-70. PubMed ID: 2477545
[TBL] [Abstract][Full Text] [Related]
2. Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P.
Edvinsson L; Erlinge D; Ekman R; Thulin T
Blood Press; 1992 Dec; 1(4):223-9. PubMed ID: 1285370
[TBL] [Abstract][Full Text] [Related]
3. Differing action potential shapes in rat dorsal root ganglion neurones related to their substance P and calcitonin gene-related peptide immunoreactivity.
McCarthy PW; Lawson SN
J Comp Neurol; 1997 Dec; 388(4):541-9. PubMed ID: 9388014
[TBL] [Abstract][Full Text] [Related]
4. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache.
Alessandri M; Massanti L; Geppetti P; Bellucci G; Cipriani M; Fanciullacci M
Cephalalgia; 2006 Nov; 26(11):1287-93. PubMed ID: 17059435
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide in the pathogenesis and treatment of hypertension.
Tang JA; Xu D; Yuan QX; Meng ZH; Cheng FR; Chen MZ; Liu GZ; Liu LS; Zhang ZK
Chin Med J (Engl); 1989 Dec; 102(12):897-901. PubMed ID: 2517732
[TBL] [Abstract][Full Text] [Related]
6. Circulating perivascular dilatory neuropeptides in hypertension.
Edvinsson L; Ekman R; Thulin T
J Hypertens Suppl; 1989 Dec; 7(6):S194-5. PubMed ID: 2483731
[TBL] [Abstract][Full Text] [Related]
7. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
[TBL] [Abstract][Full Text] [Related]
8. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
[TBL] [Abstract][Full Text] [Related]
9. No increase of calcitonin gene-related peptide in jugular blood during migraine.
Tvedskov JF; Lipka K; Ashina M; Iversen HK; Schifter S; Olesen J
Ann Neurol; 2005 Oct; 58(4):561-8. PubMed ID: 16178016
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide and tachykinins in relation to local sensory control of cardiac contractility and coronary vascular tone.
Franco-Cereceda A
Acta Physiol Scand Suppl; 1988; 569():1-63. PubMed ID: 3266056
[TBL] [Abstract][Full Text] [Related]
11. Secretory pathways of neuropeptides in rat lumbar dorsal root ganglion neurons and effects of peripheral axotomy.
Zhang X; Aman K; Hökfelt T
J Comp Neurol; 1995 Feb; 352(4):481-500. PubMed ID: 7536758
[TBL] [Abstract][Full Text] [Related]
12. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur.
Onuoha GN; Alpar EK
Neuropeptides; 2000 Apr; 34(2):116-20. PubMed ID: 10985928
[TBL] [Abstract][Full Text] [Related]
13. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
Itoh H; Naito T; Takeyama M
J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
[TBL] [Abstract][Full Text] [Related]
14. The distribution of nerve fibres immunoreactive for vasoactive intestinal peptide, calcitonin gene-related peptide, substance P and dopamine beta-hydroxylase in the normal equine larynx.
Corcoran BM; Jarvis S; Hahn CN; Mayhew IG
Res Vet Sci; 1999 Dec; 67(3):251-9. PubMed ID: 10607505
[TBL] [Abstract][Full Text] [Related]
15. Low calcitonin gene-related, peptide-like immunoreactivity in cerebrospinal fluid from chronic pain patients.
Lindh C; Liu Z; Welin M; Ordeberg G; Nyberg F
Neuropeptides; 1999 Dec; 33(6):517-21. PubMed ID: 10657534
[TBL] [Abstract][Full Text] [Related]
16. Increased substance P content in nerve fibers associated with mesenteric veins from deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Galligan JJ; Miller SB; Katki K; Supowit S; DiPette D; Fink GD
Regul Pept; 2006 Jan; 133(1-3):97-104. PubMed ID: 16297989
[TBL] [Abstract][Full Text] [Related]
17. Effect of omega-conotoxin GVIA and omega-agatoxin IVA on the capsaicin-sensitive calcitonin gene-related peptide release and autoregulatory vasodilation in rat pial arteries.
Hong KW; Kim CD; Rhim BY; Lee WS
J Cereb Blood Flow Metab; 1999 Jan; 19(1):53-60. PubMed ID: 9886355
[TBL] [Abstract][Full Text] [Related]
18. Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats.
Deng PY; Ye F; Cai WJ; Deng HW; Li YJ
Regul Pept; 2004 Jul; 119(3):155-61. PubMed ID: 15120475
[TBL] [Abstract][Full Text] [Related]
19. Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder.
Smet PJ; Moore KH; Jonavicius J
Lab Invest; 1997 Jul; 77(1):37-49. PubMed ID: 9251677
[TBL] [Abstract][Full Text] [Related]
20. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
Zoccali C; Mallamaci F; Parlongo S
J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
